← Eichor
Condition: Drug Safety Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Drug Safety

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3 · 2 location(s) · Shanghai Yizhong Pharmaceutical Co., Ltd. · NCT06752811Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Phase N/A · 73 location(s) · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT03894228Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
NA · 1 location(s) · Ryazan State Medical University · NCT05933720The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
Phase N/A · 1 location(s) · Tongji Hospital · NCT07077473Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreat
Phase 1 · 1 location(s) · GeneCradle Inc · NCT05860569Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · 16 location(s) · MRM Health NV · NCT07296315A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · 76 location(s) · Bayer · NCT04142437The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07307170Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Phase 1 · 1 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06235125Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute M
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT06484062A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability,
EARLY_Phase 1 · 4 location(s) · Suzhou Immunofoco Biotechnology Co., Ltd · NCT07376642From Administration of Oral Medicines by Nurses to Controlled Self-administration: Impact on Safety of Administration Du
NA · 1 location(s) · Centre Hospitalier de Valenciennes · NCT06639113A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Phase 1 · 7 location(s) · Shanghai Henlius Biotech · NCT07473726A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL
Phase 2 · 1 location(s) · Ascentage Pharma Group Inc. · NCT04496349A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of
Phase 1/Phase 2 · 12 location(s) · Ipsen · NCT07213817An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2 · 54 location(s) · Avalyn Pharma Inc. · NCT06951217A Study of YL242 in Subjects With Advanced Solid Tumors
Phase 1/Phase 2 · 15 location(s) · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07197827A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
Phase 1 · 11 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07390955A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Hea
Phase 1 · 1 location(s) · Pfizer · NCT06994897A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid
Phase 1 · 12 location(s) · Bristol-Myers Squibb · NCT07077434Venoactive Drug Treatment of Pelvic Venous Disorders
Phase 3 · 1 location(s) · Pirogov Russian National Research Medical University · NCT06584799Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Phase 1/Phase 2 · 12 location(s) · Ascentage Pharma Group Inc. · NCT04501120A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic
Phase 1/Phase 2 · 31 location(s) · RemeGen Co., Ltd. · NCT06016062A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Phase 1 · 14 location(s) · Ascentage Pharma Group Inc. · NCT04275518Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
Phase N/A · 6 location(s) · Maquet Cardiovascular · NCT07286890
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.